Disclosed is an isolated antibody that binds human CSF1R, comprising a heavy chain and a light chain of CDR sequences as defined in the specification. Also disclosed is the use of the said antibody in the manufacture of a medicament for treating cancer, autoimmune diseases, inflammatory conditions, or osteolytic bone loss.